Company: INDP
Filing Date: 2025-06-26
Form Type: 8-K
Source: 0001641172-25-016694
Chunk: 2

Company: Indaptus Therapeutics, Inc.
Filing Date: 2025-06-26
Form: 8-K
Item: Item 9.01
Chunk 2
---
Item       Financial                 

(d)
Exhibits.

  Exhibit      Description                                                                                                   
      No.                                                                                                                    
 ─────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
      3.1      Certificate of Amendment to Amended And Restated Certificate of Incorporation of Indaptus Therapeutics, Inc.  
     99.1      Press release, dated June 25, 2025                                                                            
      104      Cover                                                                                                         

SIGNATURES

Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.

Date:
June 26, 2025